ABVC BioPharma, Inc. Repayments of Long-Term Debt
ABVC BioPharma, Inc. (ECOC) reported Repayments of Long-Term Debt of $1.00 million for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2023-08-14
- ABVC BioPharma, Inc. repayments of long-term debt for the quarter ending 2023-06-30 was $0.00.
- ABVC BioPharma, Inc. repayments of long-term debt for the quarter ending 2023-03-31 was $1.00M.
- ABVC BioPharma, Inc. repayments of long-term debt for the quarter ending 2020-06-30 was $253.38K.
- ABVC BioPharma, Inc. repayments of long-term debt for the quarter ending 2020-03-31 was $9.98K.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month |
|---|---|---|
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $1.00M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $1.00M 10-Q · filed 2023-05-15 | |
| 2021-06-30 | $4.40K 10-Q · filed 2021-08-12 | |
| 2020-06-30 | $253.38K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $263.36K 10-Q · filed 2021-08-12 |
| 2020-03-31 | $9.98K 10-Q · filed 2021-05-10 |